Posted by: biotechbeachbum | May 27, 2009

Vertex Starts Pivotal CF Trials | Xconomy

Vertex, a Boston-based biotech with offices in San Diego, announces clinical trials of their new Cystic Fibrosis drug. It will be exciting to see how these go.
 
Cystic Fibrosis, an abnormality to a protein that regulates chloride ions in cells, is one of the most common genetic conditions in our population, and often shows up in business models that monetize gene therapies with the potential to lead to personalized medicine.
 
http://www.xconomy.com/boston/2009/05/27/vertex-starts-pivotal-cf-trials/


Leave a response

Your response:

Categories